Greg is a scientific consultant to mental health programs and psychedelic startups through his firm, Frederick Research. He’s also currently a scientific advisor on psychedelics and gathers research on how people use medicines such as psilocybin and LSD to improve their health, relationships, and careers. He is also the research director for Tech4America, a non-profit organization that looks at how access to mental health services impacts low-income individuals seeking to get into high-tech careers. His research has been featured in The New York Times, Washington Post, and The Guardian.

‍